Crescent Biopharma, Inc. (CBIO) vs Delcath Systems, Inc. (DCTH)
A side-by-side comparison of Crescent Biopharma, Inc. and Delcath Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBIO
Crescent Biopharma, Inc.
$13.70HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT
DCTH
Delcath Systems, Inc.
$15.54HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT
Total return — CBIO vs DCTH
growth of $100 · dividends reinvested · last 8yCBIO -97.3% (-36.3%/yr)DCTH -98.3% (-40.0%/yr)CBIO compounded faster over this window
CBIO DCTH
CBIO vs DCTH: by the numbers
- •DCTH is the larger company ($536M vs $509M market cap).
- •DCTH is profitable (0.56% net margin) while CBIO runs a net loss (-1371.51%).
- •DCTH grew revenue faster over the past five years (118.96% vs 39.89% CAGR).
Metrics side by side
Valuation
| Metric | CBIO | DCTH |
|---|---|---|
| P/E ratio | N/A | 1195.38 |
| P/S ratio | 42.84 | 5.62 |
| P/B ratio | 3.20 | 4.43 |
| FCF yield | N/A | 3.26% |
Profitability
| Metric | CBIO | DCTH |
|---|---|---|
| Gross margin | 100.00% | 87.05% |
| Operating margin | -1407.52% | -1.90% |
| Net margin | -1371.51% | 0.56% |
| ROE | -99.83% | 0.44% |
| ROIC | -102.59% | -0.81% |
Growth (annualized)
| Metric | CBIO | DCTH |
|---|---|---|
| Revenue CAGR (5Y) | 39.89% | 118.96% |
| Total return CAGR (5Y) | -24.40% | 10.90% |
Frequently asked
- Which has grown faster, CBIO or DCTH?
- Over the past five years, DCTH grew revenue faster — CBIO at a 39.89% CAGR versus DCTH at 118.96%.
- Is CBIO or DCTH more profitable?
- DCTH runs the higher net margin — CBIO at -1371.51% versus DCTH at 0.56%.
- How have CBIO and DCTH total returns compared?
- Over the past 5 years, CBIO delivered -24.40% and DCTH delivered 10.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Delcath Systems P/E ratioCrescent Biopharma ROEDelcath Systems ROECrescent Biopharma operating marginDelcath Systems operating marginCrescent Biopharma revenue growthDelcath Systems revenue growthCrescent Biopharma free cash flowDelcath Systems free cash flow
Crescent Biopharma & Delcath Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.